Abstract

CCL3, a member of the CC-chemokine family, has been associated with macrophage recruitment to heart tissue and parasite control in the acute infection of mouse with Trypanosoma cruzi, the causative agent of Chagas disease. Here, we approached the participation of CCL3 in chronic chagasic cardiomyopathy (CCC), the main clinical form of Chagas disease. We induced CCC in C57BL/6 (ccl3+/+) and CCL3-deficient (ccl3−/−) mice by infection with the Colombian Type I strain. In ccl3+/+ mice, high levels of CCL3 mRNA and protein were detected in the heart tissue during the acute and chronic infection. Survival was not affected by CCL3 deficiency. In comparison with ccl3+/+, chronically infected ccl3−/− mice presented reduced cardiac parasitism and inflammation due to CD8+ cells and macrophages. Leukocytosis was decreased in infected ccl3−/− mice, paralleling the accumulation of CD8+ T cells devoid of activated CCR5+ LFA-1+ cells in the spleen. Further, T. cruzi-infected ccl3−/−mice presented reduced frequency of interferon-gamma (IFNγ)+ cells and numbers of parasite-specific IFNγ-producing cells, while the T. cruzi antigen-specific cytotoxic activity was increased. Stimulation of CCL3-deficient macrophages with IFNγ improved parasite control, in a milieu with reduced nitric oxide (NOx) and tumor necrosis factor (TNF), but similar interleukin-10 (IL-10), concentrations. In comparison with chronically T. cruzi-infected ccl3+/+ counterparts, ccl3−/− mice did not show enlarged heart, loss of left ventricular ejection fraction, QTc prolongation and elevated CK-MB activity. Compared with ccl3+/+, infected ccl3−/− mice showed reduced concentrations of TNF, while IL-10 levels were not affected, in the heart milieu. In spleen of ccl3+/+ NI controls, most of the CD8+ T-cells expressing the CCL3 receptors CCR1 or CCR5 were IL-10+, while in infected mice these cells were mainly TNF+. Lastly, selective blockage of CCR1/CCR5 (Met-RANTES therapy) in chronically infected ccl3+/+ mice reversed pivotal electrical abnormalities (bradycardia, prolonged PR, and QTc interval), in correlation with reduced TNF and, mainly, CCL3 levels in the heart tissue. Therefore, in the chronic T. cruzi infection CCL3 takes part in parasite persistence and contributes to form a CD8+ T-cell and macrophage-enriched cardiac inflammation. Further, increased levels of CCL3 create a scenario with abundant IFNγ and TNF, associated with cardiomyocyte injury, heart dysfunction and QTc prolongation, biomarkers of severity of Chagas' heart disease.

Highlights

  • Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects seven to eight million people in Latin America [1]

  • Treatment of T. cruzi-infected macrophages and cardiomyocytes with tumor necrosis factor (TNF) and IFNγ induced increased the production of the CC-chemokines CCL3/MIP1α, CCL4/MIP-1β and CCL5/RANTES, which play a pivotal role in parasite growth control [10,11,12]

  • CC-chemokines acting on their receptors CCR1/CCR5 have been involved in myocarditis formation and cardiomyocyte lesion in acute and chronic T. cruzi infection [13,14,15,16]

Read more

Summary

Introduction

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects seven to eight million people in Latin America [1]. Inflammatory cells infiltrating the heart may contribute to control parasite growth, they have been involved in the perpetuation of Chagas’ heart disease [5, 6]. Pro-inflammatory cytokines, interferon gamma (IFNγ) and tumor necrosis factor (TNF) were detected in the heart tissue of chronically infected patients and proposed to be involved in parasite control, and in tissue damage [3, 7, 8]. Treatment of T. cruzi-infected macrophages and cardiomyocytes with TNF and IFNγ induced increased the production of the CC-chemokines CCL3/MIP1α (macrophage inflammatory protein-1α), CCL4/MIP-1β and CCL5/RANTES (regulated upon activation, normal T cell expressed and secreted), which play a pivotal role in parasite growth control [10,11,12]. The role of the CC-chemokine family members in cardiac tissue inflammation and injury was not clarified

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.